ELIA GROUP financials
ELIA GROUP
Country: BE Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
549300S1MP1NFDIKT460 Financial statements
(EUR, as reported — unscaled; 112 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €3.77B | €3.84B |
| Other income | €383.6M | €210.7M |
| Employee benefits expense | €471.0M | €414.5M |
| Raw materials & consumables used | €23.0M | €17.2M |
| Operating profit (EBIT) | €879.1M | €644.2M |
| Net finance income / (cost) | -€172.4M | -€119.3M |
| Finance costs | €276.5M | €181.0M |
| Profit before tax | €739.8M | €555.0M |
| Income tax expense | €227.3M | €155.5M |
| Profit for the year | €512.5M | €399.5M |
| — attributable to NCI | €62.0M | €44.1M |
| Total comprehensive income | €754.3M | €127.3M |
| Per share | ||
| Basic EPS | €5.73 | €4.41 |
| Diluted EPS | €5.73 | €4.41 |
| Free cash flow / share | €-38.86 | €-40.72 |
| Cash flow statement | ||
| Net cash from operating activities | €944.2M | -€1.51B |
| Income taxes paid | €152.7M | €159.2M |
| Net cash from investing activities | -€4.87B | -€2.29B |
| Purchase of PP&E (capex) | €4.42B | €2.18B |
| Purchase of intangibles | €255.8M | €134.3M |
| Net cash from financing activities | €4.60B | €1.01B |
| Dividends paid | €146.3M | €140.4M |
| Proceeds from borrowings | €5.34B | €2.16B |
| Repayments of borrowings | €639.9M | €787.1M |
| Balance sheet | ||
| Total assets | €24.93B | €19.39B |
| Non-current assets | €21.43B | €16.82B |
| Property, plant & equipment | €17.69B | €13.65B |
| Intangible assets & goodwill | €2.41B | €2.41B |
| Current assets | €3.50B | €2.57B |
| Inventories | €224.6M | €42.7M |
| Cash & equivalents | €2.03B | €1.37B |
| Total equity | €6.18B | €5.52B |
| — attributable to owners | €5.56B | €5.09B |
| Non-controlling interests | €621.2M | €428.8M |
| Non-current liabilities | €14.90B | €10.03B |
| Current liabilities | €3.85B | €3.84B |
| Deferred tax liabilities | €301.9M | €146.9M |
| Derived metrics | ||
| Free cash flow | -€3.48B | -€3.69B |
| Operating margin | 23.3% | 16.8% |
| Net margin | 13.6% | 10.4% |
| Return on equity | 8.3% | 7.2% |
| Cash conversion ratio | 1.84× | -3.78× |
| Capex coverage | 0.21× | -0.69× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€182.4M | -€21.5M |
| Adjustments For Decrease Increase In Other Current Assets | -€24.7M | €6.6M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€71.4M | €159.8M |
| Adjustments For Deferred Tax Expense | €76.2M | €33.6M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €618.7M | €557.4M |
| Adjustments For Fair Value Gains Losses | -€300.0K | -€200.0K |
| Adjustments For Finance Income Cost | -€172.5M | -€119.3M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | -€100.0K | €4.7M |
| Adjustments For Income Tax Expense | €151.0M | €121.9M |
| Adjustments For Increase Decrease In Other Current Liabilities | €137.1M | €180.5M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€112.3M | -€2.81B |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €14.0M | €16.5M |
| Adjustments For Provisions | -€4.2M | -€5.9M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €33.2M | €30.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €1.51B | €1.22B |
| Comprehensive Income Attributable To Noncontrolling Interests | €108.2M | -€5.9M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | €811.2M | €702.2M |
| Current Prepayments and Current Accrued Income Other Than Current Contract Assets | €44.1M | €21.4M |
| Current Provisions | €8.9M | €8.4M |
| Current Tax Assets Current | €94.3M | €64.4M |
| Current Tax Liabilities Current | €10.2M | €5.3M |
| Deferred Tax Assets | €700.0K | €2.1M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €619.4M | €557.5M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €36.0M | €26.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €146.3M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €2.05 | €1.99 |
| Dividends Received Classified As Investing Activities | €35.0M | €23.4M |
| Dividends Recognised As Distributions To Noncontrolling Interests | €36.0M | €26.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€9.9M | €0 |
| Equity and Liabilities | €24.93B | €19.39B |
| Finance Income | €104.1M | €61.6M |
| Gains Losses On Exchange Differences On Translation Before Tax | €200.0K | €0 |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €69.5M | -€112.7M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €7.4M | -€1.8M |
| Increase Decrease In Cash and Cash Equivalents | €662.2M | -€2.78B |
| Increase Decrease In Working Capital | €253.7M | €2.48B |
| Increase Decrease Through Sharebased Payment Transactions | — | €100.0K |
| Increase Decrease Through Transactions With Owners | -€94.2M | -€366.4M |
| Increase Decrease Through Transfers and Other Changes Equity | €118.2M | €23.2M |
| Intangible Assets Other Than Goodwill | €565.2M | €313.2M |
| Interest Paid Classified As Operating Activities | €238.8M | €149.3M |
| Interest Received Classified As Operating Activities | €79.8M | €62.0M |
| Investment Accounted For Using Equity Method | €512.7M | €269.1M |
| Noncurrent Provisions | €172.1M | €165.9M |
| Noncurrent Receivables | €55.0M | €55.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €61.4M | €87.1M |
| Other Adjustments For Noncash Items | €2.4M | €500.0K |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €1.6M | €0 |
| Other Comprehensive Income | €241.7M | -€272.2M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €230.5M | -€380.1M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €65.9M | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €22.0M | -€6.5M |
| Other Current Liabilities | €600.0K | €0 |
| Other Expense By Nature | €38.2M | €46.4M |
| Other Noncurrent Financial Assets | €186.3M | €121.0M |
| Other Noncurrent Liabilities | €390.5M | €371.7M |
| Payments of Other Equity Instruments | €0 | €700.0M |
| Payments To Acquire Or Redeem Entitys Shares | €1.3M | €1.0M |
| Proceeds From Contributions of Noncontrolling Interests | €120.0M | €24.0M |
| Proceeds From Issuing Other Equity Instruments | €0 | €500.0M |
| Proceeds From Issuing Shares | €0 | €600.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €2.9M | €3.3M |
| Profit Loss Attributable To Ordinary Equity Holders of Parent Entity Including Dilutive Effects | €421.3M | €324.5M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €230.4M | €0 |
| Purchase of Treasury Shares | €800.0K | €500.0K |
| Services Expense | €2.07B | €2.28B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €33.2M | €30.2M |
| Trade and Other Payables | €2.16B | €2.15B |
| Trade and Other Receivables | €1.10B | €1.07B |
Methodology
Every line item above is a fact tagged in ELIA GROUP's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.